Ligand Reaches OmniAb Platform License Agreement with Gilead
July 08, 2016 at 11:12 AM EDT
Ligand Pharmaceuticals Inc. (NASDAQ: LGND) disclosed that it reached a worldwide license agreement with Gilead Sciences, Inc. ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.